Injured women face discrimination over life-saving drugs, say researchers

Female patients in England and Wales half as likely to receive TXA, which cuts risk of bleeding to death by 30%, as injured men

Injured women are experiencing sex discrimination in the administration of a life-saving drug that cuts the risk of bleeding to death by 30%, researchers have warned.

They found that female trauma victims were half as likely to receive tranexamic acid (TXA) as injured men - even though the treatment is equally effective regardless of sex.